Breaks Categories: News

WednesdayMay 06, 2020 12:33 pm

NetworkNewsBreaks – Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) Secures $20M in Public Offering

Cyclacel Pharmaceuticals (NASDAQ: CYCC), a biopharmaceutical company developing innovative medicines based on cancer cell biology, has closed a public offering of (i) 4,000,000 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) and (ii) common warrants to purchase up to 4,000,000 shares of common stock. According to the update, each share of common stock and, as applicable, each pre-funded warrant, was sold together with a common warrant to purchase one share of common stock at a combined effective price to the public of $5.00 per share and accompanying common warrant, and/or $4.999 per pre-funded…

Continue Reading

WednesdayMay 06, 2020 11:55 am

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Collaborates with Dr. Daniel Carter to Enter Race to Develop Potential COVID-19 Vaccine

Predictive Oncology (NASDAQ: POAI) has entered the race to develop a COVID-19 vaccine with the announced acquisition of Soluble Therapeutics, Inc. and the subsequent partnership and licensing of a novel nanoparticle vaccine platform recently developed by Dr. Daniel Carter. According to the update, the groundbreaking vaccine technology being developed by Dr. Carter is based on a self-assembling nanoparticle called NSP-10 (NSP is Non Specific Protein), which follows a foundational vaccine platform developed earlier by Dr. Carter and his team, using another self-assembling protein called ferritin (1), an iron storage protein found in all living things. NIH is currently exploiting the…

Continue Reading

WednesdayMay 06, 2020 11:20 am

NetworkNewsBreaks – National Storm Recovery (NSRI) CEO Featured in Exclusive Interview to Discuss Key Milestones, Growth Strategies

National Storm Recovery (OTC: NSRI) today announced that its CEO Tony Raynor has been featured in an exclusive audio interview with NetworkNewsWire (“NNW”), a financial news and content distribution company that is part of the InvestorBrandNetwork (“IBN”). During the interview, Raynor discussed NSRI’s business model and highlighted several key milestones that have positioned the company for growth in 2020. “We entered into a three-year commitment with one of the largest disposal companies in the nation, for our recycling facility, where we manufacture products. We also entered into another three-year contract doing emergency debris and tree removal services in Oakland, Florida,”…

Continue Reading

WednesdayMay 06, 2020 10:32 am

NetworkNewsBreaks – Sugarmade, Inc. (SGMD) Receives $10M in New Orders for Sanitary and Personal Protective Supplies Amidst the Re-Opening of America

Sugarmade (OTCQB: SGMD) today announced its receipt of over $10 million in new orders for consumable sanitary supplies and non-medical personal protective items as America prepares to get back to work. As businesses across the country are scrambling for supplies in preparation to reopen, facing moral and legal obligations to protect their workers, Sugarmade’s CarryOutsupplies.com operating unit is benefiting in helping to meet this demand. “We have never seen anything like this situation. We believe we are in a unique situation relative to the re-opening of America,” Sugarmade CEO Jimmy Chan stated in the news release. “Approximately two months ago…

Continue Reading

WednesdayMay 06, 2020 10:05 am

NetworkNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Enters Agreement to Acquire Prompt Fission Neutron Equipment and Technology

Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading producer of uranium in the United States, today announced its entry into an agreement to acquire from GeoInstruments Logging LLC ("GIL") all of its Prompt Fission Neutron ("PFN") technology, equipment and related intellectual property. Under the agreement, Energy Fuels will be given the exclusive right to globally use, license and service this particular PFN technology, which is critical to successful uranium production, particularly from many in situ recovery ("ISR") deposits, as it more accurately measures downhole in-situ U3O8 ore grade versus traditional Total Gamma and Spectral Gamma methods. “Energy Fuels' acquisition…

Continue Reading

WednesdayMay 06, 2020 9:27 am

NetworkNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Names New President, Secretary; Appoints New Member to Board of Directors

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, today announced the appointment of Pat McCutcheon to the company’s board of directors, effective immediately. McCutcheon is currently the chief executive officer of one of the leading global cannabis companies, MediPharm Labs Corp. (TSX: LABS), and has held senior roles with various large pharmaceutical companies. Champignon also announced the appointment of Matthew Fish, JD as president and secretary. In his private practice as a…

Continue Reading

TuesdayMay 05, 2020 1:17 pm

NetworkNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Featured in ROTH Equity Research Report

Energy Fuels (NYSE American: UUUU) (TSX: EFR) was featured in a recent equity research report published by ROTH Capital Partners LLC. The report reads, “On May 1, 2020, UUUU released its financial and operating results for Q1 2020. Based on these results and near-term production expectations, we believe UUUU is going to wait for improved uranium price before increasing production. Due to this and recent equity transactions, we are cutting our price target from $3.25 to $2.00 and maintaining our Buy rating.” To request access to the full report, visit http://nnw.fm/DXCr3 About Energy Fuels Inc. Energy Fuels is a leading…

Continue Reading

TuesdayMay 05, 2020 12:51 pm

NetworkNewsBreaks – InvestorBrandNetwork Launches NetworkWire – Providing White-Glove Service Far Beyond Traditional Newswire Offerings

InvestorBrandNetwork (“IBN”), an innovative corporate communications agency and content distributor, today announced the launch of NetworkWire (“NW”) as part of its continued commitment to expand available options that deliver mass exposure with targeted distribution. A game-changer for companies that wish to expand the visibility of their announcements, NetworkWire combines traditional wire-grade press release dissemination with assistance from a helpful, experienced team, offering expert press release enhancement services, follow-up article syndication via a network of more than 5,000 downstream partners and multi-brand social media distribution. NetworkWire, through this unprecedented cocktail of services, effectively helps public and private companies maximize their corporate…

Continue Reading

TuesdayMay 05, 2020 12:45 pm

NetworkNewsBreaks – Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) to Announce Q1 2020 Financial Results, Host Conference Call

Xeris Pharmaceuticals (NASDAQ: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, recently announced that it will release its first quarter 2020 financial results before the opening of the U.S. financial markets on Thursday, May 7, 2020. Per the update, Xeris management will host a conference call at 8:30 a.m. ET on the same day to discuss the Company’s financial and operational results. Interested parties may participate by dialing (866) 951-8137 (domestic) or (270) 215-9500 (international) and referencing conference ID 4666547. The live webcast will be accessible on…

Continue Reading

TuesdayMay 05, 2020 12:34 pm

NetworkNewsBreaks – Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) Secures $80.5 Million in Underwritten Public Offering

Arcturus Therapeutics Holdings (NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines, has closed an underwritten public offering of 4,735,297 shares of its common stock, including 617,647 additional shares pursuant to the full exercise of the over-allotment granted to the underwriters. According to the update, Arcturus Therapeutics secured approximately $80.5 million in gross proceeds, with each of the shares sold at the public offering price of $17.00. The company intends to use the proceeds for working capital and general corporate purposes, which may include R&D and…

Continue Reading